🇺🇸 FDA
Company

MiNK

MiNK Therapeutics

INKT biotech USA

Quick answer

MiNK is a biotech company (INKT) headquartered in NEW YORK, NY, USA with 3 tracked pipeline programs.

Pipeline (3)

project

agenT-797

Relapsed/Refractory Multiple Myeloma

Phase 1 · small_molecule · completed

1 trials project

agenT-797

Respiratory Distress Syndrome, Adult

Phase 1 · small_molecule · completed

1 trials project

agenT-797

Tumor, Solid

Phase 1 · small_molecule · completed

1 trials

Patents (6)

patent

US 12419955

Method for efficiently infecting human natural killer cells and other immune cel

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12391741

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11898165

Engineered host cells and methods of use thereof

Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11718658

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti

Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11613764

T cell receptors that bind to NY-ESO-1 and methods of use thereof

Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9943496

Dietary supplement based on ethyl ferulate

Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)